Terns Pharmaceuticals
TERN
TERN
157 hedge funds and large institutions have $477M invested in Terns Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 67 increasing their positions, 33 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+2
Holders Change %
+1.29%
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
38
Increased
67
Reduced
33
Closed
35
Calls
$3.7M
Puts
$869K
Net Calls
+$2.83M
Net Calls Change
-$1.46M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$14.2M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$11.9M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.6M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$8.1M |
| 5 |
BlackRock
New York
|
+$5.79M |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$17.8M |
| 2 |
VA
VR Adviser
New York
|
-$12.9M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$9.08M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.06M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.86M |
